Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07322588 · ClinicalTrials.gov registry record · NA
Reentry Incentives and Support for Engagement With Contingency Management
A NA study, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT07322588 is a NA study that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 75 participants.
The verdict
NCT07322588, a NA study, has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community. In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions. Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD. The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.
Interventions
- OTHER Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07322588
The ClinicalTrials.gov registry entry for NCT07322588 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention is the first listed.
NCT07322588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07322588 about?
NCT07322588 is a clinical study titled "Reentry Incentives and Support for Engagement With Contingency Management". People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers reward...
What is the current status of trial NCT07322588?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-01. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07322588?
The interventions under investigation include: Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention (OTHER).
Who is sponsoring clinical trial NCT07322588?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.